
Published 05 October 2026
An Appetite Rebellion is emerging as millions of individuals renegotiate their relationship with food – not only due to GLP‑1 use, but because years of restriction, optimisation and appetite‑suppression have disconnected people from hunger, pleasure and trust. As consumers push back against Ozempic‑driven ‘small eating’ and others adjust to altered appetite cues while taking or coming off the drugs, nourishment, taste and satisfaction are regaining cultural and social resonance.



Offering access to over 350 consumer and cross-industry reports annually, Stylus Membership is your window to tomorrow’s most exciting opportunities.
We already arm more than 500 of the world’s most forward-thinking brands and agencies with the creative insights they need to make transformative business decisions.
We’d love to do the same for you.
Book a demo with us today to discover more.
GLP-1 medications are reshaping food culture, kitchens and everyday consumption patterns. While homes adapt with portion-focused tools, single-meal appliances and waste-reduction storage, users are prioritising protein, fibre and nutritional value per bite – impacting grocery basket composition and spending. Alongside...